Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.19
Delayed Data
As of Feb 22
 +0.29 / +3.67%
Today’s Change
5.77
Today|||52-Week Range
9.88
-4.43%
Year-to-Date

Today’s Trading

Previous close7.90
Today’s open7.92
Day’s range7.71 - 8.30
Volume753,751
Average volume (3 months)307,524
Market cap$620.3M
Dividend yield--
Data as of 02/22/2017

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+126.67%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc-0.02-0.20%
NVTAInvitae Corp-0.12-1.17%
FMIFoundation Medicine ...-0.60-2.45%
PTIProteostasis Therape...-0.32-2.12%
Data as of 02/22/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.04
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs